Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2).
Serological surveillance is an important resource to evaluate vaccine programmes, especially for diseases such as rubella, where a sub-optimal programme can lead to an increase in morbidity. A coordinated vaccine policy in Europe is needed and the aim of the European Sero-Epidemiology Network (ESEN2) is to standardise serological surveillance in 22 countries for eight diseases, including rubella.
Nardone
A
A
Health Protection Agency, CDSC, London, UK.
Miller
E
E
D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D011159:Population Surveillance; D011247:Pregnancy; D012409:Rubella / Q000097:blood* / Q000453:epidemiology* / Q000517:prevention & control; D012411:Rubella Vaccine; D016036:Seroepidemiologic Studies
D012411:Rubella Vaccine